For this reason, blockade of glucagon receptor (GCGR) signalling has been widely regarded as a potential therapeutic option to help control blood glucose levels for the treatment of diabetes (Patil et al. 2020, Lafferty et al. 2021). This evidence concerns the gene GCGR and diabetes mellitus.